ER

Elango Ravirajasekar

Active Director Designated Partner DIN 06852851
DIN 06852851 First appointment Jun 2014 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Elango Ravirajasekar

Data last updated:

Elango Ravirajasekar is a Designated Partner at Karur Doctors Pharma Llp (since 2014). The company operates in Business Services.

DIN 06852851
Primary Designation Designated Partner
Industry Business Services
First Appointment 09 Jun 2014
Oldest Company Age 12 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Jun 20142014Active

Board colleagues of Elango Ravirajasekar

Directorship timeline

Open interactive timeline →
Karur Doctors Pharma Llp
Premium access

Shareholding and investment profile for Elango Ravirajasekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elango Ravirajasekar

Elango Ravirajasekar currently holds 1 directorship: Karur Doctors Pharma Llp (Designated Partner, since 09 Jun 2014).

Elango Ravirajasekar was first appointed on 09 Jun 2014 as Designated Partner at Karur Doctors Pharma Llp.

The current boards of Elango Ravirajasekar's companies include Chidambaram Natarajan Raman (Karur Doctors Pharma Llp), Kulandaiappan Chellappan Balasubramaniam (Karur Doctors Pharma Llp), Manohar Rajalingam (Karur Doctors Pharma Llp), Rengasamy Karuppaiya (Karur Doctors Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available